Deborah H. Telman - 25 Apr 2024 Form 4 Insider Report for GILEAD SCIENCES, INC. (GILD)

Role
EVP, Corporate Affairs & GC
Signature
/s/ Edward S. Son by Power of Attorney for Deborah H. Telman
Issuer symbol
GILD
Transactions as of
25 Apr 2024
Net transactions value
-$10,313
Form type
4
Filing time
26 Apr 2024, 16:30:43 UTC
Previous filing
12 Mar 2024
Next filing
14 May 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GILD Common Stock Options Exercise +515 +3.7% 14,272 25 Apr 2024 Direct F1
transaction GILD Common Stock Tax liability $10,313 -158 -1.1% $65.27 14,114 25 Apr 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GILD Restricted Stock Unit Options Exercise -515 -1.3% 39,568 25 Apr 2024 Common Stock 515 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.
F2 The restricted stock units have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested.